Home › Leukemia › Nebraska › Omaha
Leukemia clinical trials in Omaha, NE
6 studies for Leukemia are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- University of Nebraska Medical Center, Omaha
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Recruiting
- University of Nebraska Medical Center, Omaha
Halt Aging in Survivors of Blood Cancers
Recruiting
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Omaha
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.